TORRE 42 - PEDRO BRETCHA - B

PedroBretcha Boix

Specialty:
General and GI surgery / Medical oncology
Serving specialties:
  • General and GI surgery
  • Laparoscopic surgey
Hospitals where he/she works:
  • Hospital Quirónsalud Torrevieja
General Information

Since February 2001, she has been working at the Hospital Quirónsalud Torrevieja as a founding member of the Oncology Platform within a multidisciplinary team and implementing multiple oncological techniques. To highlight the first isolated perfusion of liver with melphalan and hyperthermia in the country, as well as the treatment of peritoneal carcinomatosis by cytoreductive surgery + perioperative intraperitoneal chemo-hyperthermia (HIPEC), intraoperative radiotherapy, oncological liver rescue surgery, pancreas, pelvis, etc.

Responsible for the program of robotic surgery in digestive cancer. To highlight the realization of the first Robotic Pancreatic Surgery in the country, as well as other oncological procedures through minimal invasion.

Specialities that it attends:

Cirugía General y Aparato Digestivo

Oncological Platform: (+34) 966 925 733

Information and medical appointment

(+34) 966 921 313 / (+34) 966 925 761

Experience
Degree
  • Licenciatura en Medicina y Cirugía por la Universidad Autónoma de Barcelona en la Unidad docente del Hospital Universitario del Valle de Hebrón
  • Doctor en Medicina por la Universidad Miguel Hernandez
Pathologies
  • :
    Cirugía General Cirugía del Aparato Digestivo Cirugía Oncológica
Publications
  • Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin. Outcomes after 7 years experience of a new centre for peritoneal surface malignancies. P. Bretcha. J. Farré. Clin Transl Oncol(2010) 12:437-44
  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol. 2007 Jan;14(1):128-33.
Communications and Presentations
  • Annual Cancer Symposium Society of Surgical Oncology (San Diego, 2019)
  • 11th International Workshop on Peritoneal Surface Malignancy (Paris, 2018)
  • 38th Congress of the European Society of Surgical Oncology (Budapest, 2018)
Awards and certifications
  • Miembro de la European Society of Surgical Oncology
  • Miembro de la American Society of Surgical Oncology
  • Miembro de la Sociedad Española Oncología Quirúrgica
  • Miembro de la Asociación Española de Cirujanos
  • Miembro de la International Peritoneal Surface Malignancy Group
  • Miembro del Grupo Español de Cirugía Oncológica Peritoneal
  • Miembro de la Sociedad Española de Cirugía Laparoscópica y Robótica